INCY
Incyte
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: INCY
- PEG Ratio
As of Jul 2, 2026, INCY's PEG ratio of 0.01 reflects its valuation relative to its growth rate. This result reflects a P/E ratio of 16.03 measured against EPS growth of 2413.8%. When compared to the trailing 4-quarter average of 0.01, INCY's PEG ratio reflects a 100% increase.
INCY PEG ratio history
Incyte's ten years historical PEG ratio has a mean of 0.19. Compared to historical data, INCY's 0.01 PEG ratio represents a drop of 95%. INCY hit its maximum PEG ratio of 0.91 during the Dec 2018 quarter over the last ten years. The Sep 2025 quarter marked the lowest reading at 0, indicating the most favorable growth-adjusted valuation.
Incyte PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0 | 14.99 | 4,018.8% |
| 2024 | N/A | 431.69 | -94% |
| 2023 | 0.32 | 23.52 | 74.5% |
| 2022 | N/A | 52.5 | -64.4% |
| 2021 | 0.04 | 17.07 | 416.2% |
| 2020 | N/A | N/A | -165.4% |
| 2019 | 0.14 | 41.98 | 300% |
| 2018 | 0.91 | 122.29 | 134% |
| 2017 | N/A | N/A | -378.2% |
| 2016 | 0.14 | 182.31 | 1,275% |
| 2015 | 23.82 | 2,711.25 | 113.8% |
| 2014 | N/A | N/A | 48.2% |
| 2013 | N/A | N/A | -64.7% |
| 2012 | N/A | N/A | 77.2% |
| 2011 | N/A | N/A | -473.1% |
Incyte PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.01 | 12.91 | 2,413.8% |
| Dec 2025 | 0 | 14.99 | 4,018.8% |
| Sep 2025 | 0 | 14.04 | 3,452.9% |
| Jun 2025 | 0.01 | 15.41 | 1,063.2% |
| Mar 2025 | N/A | 208.79 | -91.3% |
| Dec 2024 | N/A | 431.69 | -94% |
| Sep 2024 | N/A | 388.82 | -91% |
| Jun 2024 | N/A | 159.53 | -76.8% |
| Mar 2024 | 0.13 | 17.11 | 128.1% |
| Dec 2023 | 0.32 | 23.52 | 74.5% |
| Sep 2023 | N/A | 30.57 | -52.3% |
| Jun 2023 | N/A | 37.96 | -61.6% |
| Mar 2023 | N/A | 49.5 | -65.4% |
| Dec 2022 | N/A | 52.5 | -64.4% |
| Sep 2022 | 0.27 | 16.83 | 63% |
INCY average PEG ratio chart
When comparing to historical data, INCY's PEG ratio is lower than the 3, 5 and 10-year averages.
PEG comparison
With a PEG of 0.01, INCY stands lower than the Healthcare sector, the industry and its peers average. Looking at the Healthcare sector average of 0.6, Incyte's PEG is 98% lower.
INCY EPS growth
INCY Price vs fair value
INCY PEG vs peers
INCY reports a PEG ratio lower than that of peer stocks LLY and NVS. At 0.01, Incyte's PEG ratio is lower than the peer group average of 0.96.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| INCY Incyte Corp | 0.01 | $23.35B |
| LGND Ligand Pharmaceuticals Inc | 0.19 | $6.4B |
| LLY ELI LILLY & Co | 0.34 | $1.14T |
| AMGN Amgen Inc | 0.83 | $201.93B |
| NVS Novartis AG | 2.48 | $305.1B |
| PFE Pfizer Inc | N/A | $138.61B |
| ARDX Ardelyx Inc | N/A | $1.3B |
| GERN Geron Corp | N/A | $872.47M |
Frequently asked questions
What is Incyte's PEG ratio?
INCY's Jul 2, 2026 PEG ratio comes in at 0.01.
What is the 3-year average PEG ratio for Incyte (INCY)?
Historical data over a 3-year period puts INCY's average PEG ratio at 0.08.
What is the 5-year average PEG ratio for Incyte (INCY)?
Historical data over a 5-year period puts INCY's average PEG ratio at 0.11.
What is the highest PEG ratio for INCY?
In the last ten years, INCY's peak PEG ratio of 0.91 occurred in the Dec 2018 quarter.
How does the current PEG ratio for INCY compare to its historical average?
At present, INCY's PEG ratio is 95% lower than its 10-year historical average.
Why is Incyte's PEG ratio so low?
The 0.01 PEG ratio for INCY reflects robust earnings growth outpacing the current valuation.
How is INCY's PEG ratio calculated (Incyte PEG ratio formula)?
Computing the PEG ratio involves dividing the PE ratio by the company's earnings per share growth (YoY TTM). As of Jul 2, 2026, Incyte has a PE ratio of 16.03. Earnings grew at 2413.8% over the TTM period ending Mar 2026. Applying the formula, this gives a PEG ratio of 0.01. PEG RATIO(0.01) = PE RATIO(16.03) / EPS GROWTH(2413.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.